David de Semir Selected Research

David de Semir Research Topics

12	Neoplasms (Cancer) 01/2023 - 01/2015
8	Melanoma (Melanoma, Malignant) 01/2021 - 03/2009
2	Breast Neoplasms (Breast Cancer) 01/2018 - 04/2016
1	Cutaneous Malignant Melanoma 01/2021
1	Cholangiocarcinoma 10/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Triple Negative Breast Neoplasms 04/2016
1	Neoplasm Metastasis (Metastasis) 03/2009
1	Cystic Fibrosis (Mucoviscidosis) 07/2003

5	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2010
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 01/2020
2	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 01/2020 - 01/2018
2	MicroRNAs (MicroRNA)IBA 08/2019 - 01/2015
1	Circulating Tumor DNAIBA 11/2022
1	Cell-Free Nucleic AcidsIBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2020
1	dinaciclibIBA 10/2020
1	Gemcitabine FDA Link 10/2020
1	VinculinIBA 01/2020
1	PaxillinIBA 01/2020
1	Drug CombinationsIBA 01/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	Complementary DNA (cDNA)IBA 01/2020
1	IntegrinsIBA 01/2020
1	TalinIBA 01/2020
1	Cyclin D1IBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 04/2016
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	Small Interfering RNA (siRNA)IBA 02/2015
1	fetal Alzheimer antigenIBA 02/2015
1	Decitabine FDA Link 08/2010
1	Messenger RNA (mRNA)IBA 08/2010
1	hammerhead ribozymeIBA 03/2009
1	Catalytic RNA (Ribozymes)IBA 03/2009
1	OligonucleotidesIBA 07/2003
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 07/2003